What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
T2 · Outlet reportThe GuardianDec 19, 2025
The article discusses a controversial $1.6 million US plan to study hepatitis B vaccination of newborns in Guinea-Bissau, West Africa. Experts have criticized the plan as "highly unethical" and "extremely risky," describing it as a…
View source →T2 · Outlet reportWiredDec 16, 2025
The article discusses the appointment of Yale epidemiologist Harvey Risch as the new head of the President's Cancer Panel. Risch has previously speculated about a potential link between COVID-19 vaccines and "turbo cancer," and has also…
View source →T2 · Outlet reportThe GuardianDec 6, 2025
The article discusses concerns from pediatricians and experts regarding changes to the US childhood vaccine schedule. A government panel has taken up discussions on the safety and efficacy of vaccines, leading to a change in the hepatitis…
View source →T2 · Outlet reportBBCDec 6, 2025
The US advisory panel has voted to end the recommendation for the hepatitis B vaccine to be given to all newborns. This decision was welcomed by President Trump, who has instructed the health department to explore further changes to the…
View source →T2 · Outlet reportThe GuardianDec 5, 2025
The CDC's vaccine advisers have voted to limit the availability of the hepatitis B vaccine in the United States. This is a significant move that signals a shift in the government's approach to vaccines that have been safely and effectively…
View source →T2 · Outlet reportNYTDec 4, 2025
Former FDA commissioners have expressed deep concern over a leaked memo from the Trump administration's chief scientific officer that suggests changing vaccine approval policies. The 12 former commissioners, writing in the New England…
View source →